ADINOLFI, Luigi Elio
 Distribuzione geografica
Continente #
NA - Nord America 9.431
EU - Europa 8.363
AS - Asia 1.861
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 17
OC - Oceania 3
Totale 19.720
Nazione #
US - Stati Uniti d'America 9.385
IE - Irlanda 2.696
UA - Ucraina 1.396
GB - Regno Unito 1.071
IT - Italia 1.015
DE - Germania 810
CN - Cina 739
SG - Singapore 620
SE - Svezia 431
FI - Finlandia 362
TR - Turchia 335
GR - Grecia 232
FR - Francia 211
KR - Corea 60
CA - Canada 37
IN - India 34
BE - Belgio 32
NL - Olanda 25
EU - Europa 20
RO - Romania 18
RU - Federazione Russa 18
IR - Iran 17
CZ - Repubblica Ceca 15
BR - Brasile 14
HK - Hong Kong 13
JP - Giappone 9
ID - Indonesia 8
IL - Israele 8
TW - Taiwan 7
EG - Egitto 6
MX - Messico 6
PL - Polonia 5
SC - Seychelles 4
BG - Bulgaria 3
CL - Cile 3
CO - Colombia 3
ES - Italia 3
LT - Lituania 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
VN - Vietnam 3
AU - Australia 2
CH - Svizzera 2
HR - Croazia 2
LI - Liechtenstein 2
MA - Marocco 2
MK - Macedonia 2
MY - Malesia 2
PK - Pakistan 2
UG - Uganda 2
AN - Antille olandesi 1
AR - Argentina 1
AT - Austria 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
EC - Ecuador 1
HU - Ungheria 1
JM - Giamaica 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PA - Panama 1
SA - Arabia Saudita 1
TN - Tunisia 1
TZ - Tanzania 1
UZ - Uzbekistan 1
Totale 19.720
Città #
Dublin 2.690
Jacksonville 2.126
Santa Clara 1.666
Chandler 1.312
Princeton 419
Singapore 385
Roxbury 313
Bremen 299
Medford 253
Ann Arbor 218
Boardman 217
New York 204
Wilmington 192
Woodbridge 186
Cambridge 183
San Mateo 125
Ashburn 118
Nanjing 108
Beijing 107
Düsseldorf 102
Caserta 96
Des Moines 82
Mountain View 73
Jinan 67
Napoli 65
Seoul 56
Shenyang 54
Naples 53
Norwalk 41
Nanchang 40
Venice 33
Helsinki 32
Brussels 31
Zhengzhou 28
Los Angeles 27
Munich 25
Washington 24
Haikou 23
Tianjin 23
Milan 22
Changsha 21
Hangzhou 20
Houston 20
Shanghai 20
Auburn Hills 18
Guangzhou 18
Hebei 18
Kunming 18
Ningbo 18
Marano Di Napoli 16
Taizhou 16
Lanzhou 15
Hong Kong 13
Redwood City 13
Palermo 12
Toronto 12
Rome 11
Taiyuan 11
Dearborn 10
Ottawa 10
Perugia 10
Zanjan 10
Amsterdam 9
Andover 9
Groningen 9
Istanbul 9
London 9
Orange 9
Pozzuoli 9
Sacramento 9
Timisoara 9
Elora 8
Fairfield 8
Jiaxing 8
Seattle 8
Torino 8
Bologna 7
Changchun 7
Hefei 7
Paris 7
Philadelphia 7
Tel Aviv 7
Brno 6
Duncan 6
Eboli 6
Florence 6
Gioi 6
Pune 6
Sesto Calende 6
Moscow 5
Taipei 5
Atlanta 4
Avellino 4
Bari 4
Buffalo 4
Cornigliano 4
Frattamaggiore 4
Grafing 4
Lappeenranta 4
Leawood 4
Totale 12.699
Nome #
Sviluppo di un questionario autocompilato per la valutazione delle opinioni dei familiari sulle cause e le conseguenze psicosociali della schizofrenia (QOF) 121
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 117
Endocardite da Gemella morbillorum: descrizione di due casi 115
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 104
Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study 100
Clinical efficacy of dirithromycin versus miocamycin in tonsillopharyngitis 95
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 95
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 94
Bioelectrical impedance analysisfor the assessment of body composition in patients with systemic sclerosis 94
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 91
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 87
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 84
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 83
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 83
Crioglobulinemia mista essenziale associata a cirrosi epatica: aspetti clinici e terapeutici.Esperienza su una casistica clinica 78
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 78
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 78
effetto di concentrazioni subinibenti ed effetto intrafagocitico di aztreonam, cefamandolo e netilmicina 77
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 77
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 74
Antimicrobici e sistema immune dell'ospite: bioattività intrafagocitica di antibiotici beta-lattamici 73
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 73
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 73
A genic and epigenetic combination therapy for liver cancer 73
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 72
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 70
Chronic HCV infection and neurological and psychiatric disorders: an overview. 69
Le complicanze infettive in pazienti sottoposti a trapianto di cuore: dati del centro napoletano. 69
Activity of aminoglycosides against phagocytosed bacteria 68
HCV RNA levels in serum, liver and PBMC of chronic hepatitis C patients: pathological and therapeutic significance. 68
Sonoporation by microbubbles as gene therapy approach against liver cancer 68
Pleurite da Listeria monocytogenes in un paziente con cirrosi epatica: osservazione di un caso clinico 67
All-oral interferon-free treatments: The end of hepatitis C virus story, the dream and the reality 67
Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study 67
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. 66
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 66
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin 65
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 65
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 65
Resistance to aminoglycosides and other antibiotics among clinical isolates of Enterococcus spp 64
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 64
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 64
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 64
An in-vitro study of treatment of drug-induced cholestasis by tauroursodeoxycholate (TUDC). 64
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 64
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 64
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 64
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 64
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 63
Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci 63
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 63
Antimicrobials and biological activities of immune system. Relazione al " Bologna,pag. 3-10. 63
Acute rhabdomiolisys in healthy woman. 63
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 62
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 62
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 62
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 62
Disordini immunologici in corso di epatite cronica da HCV: prevalenza significato clinico ed implicazioni terapeutiche. 62
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 62
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 62
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 62
Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody 61
Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. 61
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 61
Le infezioni respiratorie da Branhamella catarrhalis in pazienti sottoposti a trapianto di cuore. 61
Complicanze infettive in pazienti sottoposti a trapianto di cuore. 61
PATHOGENESIS AND SIGNIFICANCE OF HCV STEATOSIS.An update on survival strategy of a successful pathogen 60
Unusually high rate of hepatic comorbidity with Streptococcus bovis endocarditis: trend or coincidence? 60
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 60
Effects of long-term alfa interferon treatment in 344 patients with chronic hepatitis C: retrospective analysis of dosage and type of interferon used 59
Steatosi associata ad HCV e steatosi metabolica. Patologie diverse o sovrapposte? 59
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 59
Effects of bacterial lipopolysaccharide (LPS) on chlorpromazine (CPZ) induced cholestasis in the isolated perfused rat liver 59
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B 59
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 59
Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study 58
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 58
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 58
Severe diarrhea occurring during alpha-interferon treatment for chronic hepatitis C is associated with serologic markers of celiac disease 58
Circulating MiRNA-195-5p and -451a in Diabetic Patients with Transient and Acute Ischemic Stroke in the Emergency Department 58
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C 57
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 57
Problemi diagnostici e terapeutici dell'amebiasi: presentazione di due casi clinici 57
Mild chronic hepatitis C with steatosis: Which treatment? 57
Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study 57
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 57
Bacterial endotoxin treatment ameliorates erythromycin estolate-induced cholestasis in the isolated perfused rat liver 57
Chronic endotoxin pretreatment protects from the chlorpromazine induced cholestasis 57
Le infezioni cardiovascolari severe:patogeni emergenti e problematiche terapeutiche 57
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 57
Discriminating value of serum bile acids in asymptomatic HBsAg carriers 57
Chronic Hepatitis C in off therapy oncologic children: natural history and effect of interferon treatment 57
Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts 56
Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis 56
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee 56
Liver toxicity during copper chronic intoxication in rats 56
Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate 56
HCV-related steatosis and risk of atherosclerosis 56
Antibiotici 56
Hepatitis C and cardiovascular risk: facts and controversies 56
Totale 6.777
Categoria #
all - tutte 89.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.727


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020879 0 0 0 0 0 44 444 74 141 61 89 26
2020/20213.109 269 28 362 137 651 34 430 358 16 416 309 99
2021/20222.588 145 9 32 60 881 22 29 67 110 220 218 795
2022/20235.219 464 88 63 394 686 407 17 335 2.513 43 104 105
2023/20241.984 150 70 77 175 722 243 24 63 8 22 131 299
2024/20252.256 26 79 86 131 997 937 0 0 0 0 0 0
Totale 20.307